Niektóre kraje już zatwierdziły szczepionki z Chin lub obecnie uczestniczą w próbach. Ale jak skuteczne i bezpieczne są te szczepionki?
Post
Post
Post
FDA approves Janssen (Johnson & Johnson) COVID-19 Vaccine
85% effective in preventing severe/critical COVID-19 occurring at least 28 days after vaccination.
Post
Post
European Medicines Agency: clarification on Sputnik V vaccine in the EU approval process
The Sputnik V developers have received scientific advice from EMA providing them with the latest regulatory and scientific guidance for the development of their vaccine
Post
New Variants of the Virus that Causes COVID-19
Viruses constantly change through mutation, and new variants of a virus are expected to occur over time
Post
Safe COVID-19 vaccines for Europeans
Contracts have been concluded with 6 promising vaccine developers, securing a portfolio of more than 2.3 billion doses. By summer 2021, Member States should have vaccinated a minimum of 70% of the entire adult population.
Post
European Commission authorises AstraZeneca, the third safe and effective vaccine against COVID-19
The vaccine causes the immune system (the body's natural defences) to produce antibodies and specialised white blood cells that work against the virus, so giving protection against COVID-19.
Post
Breathlessness after COVID-19
The feeling of shortness of breath may continue for a while after your illness. This is a normal part of the recovery process.
Post
COVID-19 Vaccine Moderna is now authorised across the EU. This follows the granting of a conditional marketing authorisation by the European Commission
A very large clinical trial showed that COVID-19 Vaccine Moderna was effective at preventing COVID-19 in people from 18 years of age.